News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

UW institute led by Nobel Laureate uses AI to develop ‘off switch’ for cancer drugs and other applications
Researchers at the University of Washington’s Institute for Protein Design have engineered a synthetic protein using AI that can “turn off” the action of molecules

‘Virtual medicine cabinet’ from Seattle startups will put health tech apps in one place
A “virtual medicine cabinet” platform is being launched by Seattle health tech startups Wavely and Apertur to consolidate AI-powered diagnostic tools in one place. Wavely

Swiss eye-care giant acquires Poulsbo medical device firm
Alcon has acquired Poulsbo-based LumiThera, a medical device company developing treatments for age-related macular degeneration (AMD). The company developed the Valeda Light Delivery System, which

Seattle’s new frontier: Biotech, AI and the race to revolutionize medicine
Seattle has established itself as a leading hub at the intersection of biotech and AI, with growing investment and institutional support. A recent Seattle Children’s

Fred Hutch leaders raise $10M for new AI startup aiming to expedite drug discovery
Synthesize Bio, a Seattle-based startup founded by leaders from Fred Hutchinson Cancer Center, announced $10 million in funding from Madrona Venture Group to develop an

Ranking cities by AI startup funding: Bay Area dominates, Seattle is No. 4
Seattle ranked fourth nationally for AI startup funding, capturing 5.1 percent of U.S. investment, behind the Bay Area, New York, and Boston. The report highlights

AGC Biologics Seattle Facility Achieves Regulatory and Operational Milestones
AGC Biologics’ Seattle facility has achieved major regulatory and operational milestones in 2025. The site passed an FDA surveillance inspection, secured approvals in ten countries,

BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose
Bristol Myers Squibb and BioNTech reported promising global Phase 2 data for a PD-L1×VEGF bispecific drug in first-line extensive-stage small cell lung cancer. The therapy

Startup spun out of Nobel Laureate’s lab teams with Eli Lilly to fight cancer with AI
Lila Biologics, a spinout from Nobel Laureate David Baker’s lab at the University of Washington, announced a collaboration with pharmaceutical giant Eli Lilly to develop

Philips rolls out major AI upgrades to cardiac ultrasound platforms
Philips announced a sweeping set of AI upgrades to its cardiac ultrasound systems, aiming to improve diagnostic accuracy and streamline workflows for clinicians. The improvements

Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and tech
Microsoft co-founder Paul Allen’s final philanthropic act is the creation of the Fund for Science and Technology (FFST), a new foundation supported by a $3.1

Paul Allen’s Ai2 to create open-source AI tools for scientists
The Allen Institute for AI in Seattle will lead a new $152 million initiative to make AI more helpful for academic researchers, marking a shift
